BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17681275)

  • 21. A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation.
    Lee EF; Czabotar PE; van Delft MF; Michalak EM; Boyle MJ; Willis SN; Puthalakath H; Bouillet P; Colman PM; Huang DC; Fairlie WD
    J Cell Biol; 2008 Jan; 180(2):341-55. PubMed ID: 18209102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma.
    Teshima K; Nara M; Watanabe A; Ito M; Ikeda S; Hatano Y; Oshima K; Seto M; Sawada K; Tagawa H
    Oncogene; 2014 Apr; 33(17):2191-203. PubMed ID: 23686310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the proapoptotic BH3-only protein BIM by glucocorticoids, survival signals and proteasome in chronic lymphocytic leukemia cells.
    Iglesias-Serret D; de Frias M; Santidrián AF; Coll-Mulet L; Cosialls AM; Barragán M; Domingo A; Gil J; Pons G
    Leukemia; 2007 Feb; 21(2):281-7. PubMed ID: 17151701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.
    Huntington ND; Puthalakath H; Gunn P; Naik E; Michalak EM; Smyth MJ; Tabarias H; Degli-Esposti MA; Dewson G; Willis SN; Motoyama N; Huang DC; Nutt SL; Tarlinton DM; Strasser A
    Nat Immunol; 2007 Aug; 8(8):856-63. PubMed ID: 17618288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.
    Zantl N; Weirich G; Zall H; Seiffert BM; Fischer SF; Kirschnek S; Hartmann C; Fritsch RM; Gillissen B; Daniel PT; Häcker G
    Oncogene; 2007 Oct; 26(49):7038-48. PubMed ID: 17486061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1.
    Wang YF; Jiang CC; Kiejda KA; Gillespie S; Zhang XD; Hersey P
    Clin Cancer Res; 2007 Aug; 13(16):4934-42. PubMed ID: 17652623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Negative feedback loop in the Bim-caspase-3 axis regulating apoptosis and activity of osteoclasts.
    Wakeyama H; Akiyama T; Takahashi K; Amano H; Kadono Y; Nakamura M; Oshima Y; Itabe H; Nakayama KI; Nakayama K; Nakamura K; Tanaka S
    J Bone Miner Res; 2007 Oct; 22(10):1631-9. PubMed ID: 17592965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis.
    Scatizzi JC; Bickel E; Hutcheson J; Haines GK; Perlman H
    Arthritis Rheum; 2006 Oct; 54(10):3182-93. PubMed ID: 17009248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JNK mediates UVB-induced apoptosis upstream lysosomal membrane permeabilization and Bcl-2 family proteins.
    Bivik C; Ollinger K
    Apoptosis; 2008 Sep; 13(9):1111-20. PubMed ID: 18651223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circumvention of Mcl-1-dependent drug resistance by simultaneous Chk1 and MEK1/2 inhibition in human multiple myeloma cells.
    Pei XY; Dai Y; Felthousen J; Chen S; Takabatake Y; Zhou L; Youssefian LE; Sanderson MW; Bodie WW; Kramer LB; Orlowski RZ; Grant S
    PLoS One; 2014; 9(3):e89064. PubMed ID: 24594907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation and down-regulation of Bim by muscarinic cholinergic receptor activation via protein kinase C.
    Styles NA; Zhu W; Li X
    Neurochem Int; 2005 Dec; 47(8):519-27. PubMed ID: 16183168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Degradation of Mcl-1 by granzyme B: implications for Bim-mediated mitochondrial apoptotic events.
    Han J; Goldstein LA; Gastman BR; Froelich CJ; Yin XM; Rabinowich H
    J Biol Chem; 2004 May; 279(21):22020-9. PubMed ID: 15014070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
    Gillespie S; Borrow J; Zhang XD; Hersey P
    Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marinopyrrole derivatives with sulfide spacers as selective disruptors of Mcl-1 binding to pro-apoptotic protein Bim.
    Cheng C; Liu Y; Balasis ME; Garner TP; Li J; Simmons NL; Berndt N; Song H; Pan L; Qin Y; Nicolaou KC; Gavathiotis E; Sebti SM; Li R
    Mar Drugs; 2014 Jul; 12(8):4311-25. PubMed ID: 25076060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.
    Tahir SK; Yang X; Anderson MG; Morgan-Lappe SE; Sarthy AV; Chen J; Warner RB; Ng SC; Fesik SW; Elmore SW; Rosenberg SH; Tse C
    Cancer Res; 2007 Feb; 67(3):1176-83. PubMed ID: 17283153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural insights into the degradation of Mcl-1 induced by BH3 domains.
    Czabotar PE; Lee EF; van Delft MF; Day CL; Smith BJ; Huang DC; Fairlie WD; Hinds MG; Colman PM
    Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6217-22. PubMed ID: 17389404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation.
    Wiggins CM; Tsvetkov P; Johnson M; Joyce CL; Lamb CA; Bryant NJ; Komander D; Shaul Y; Cook SJ
    J Cell Sci; 2011 Mar; 124(Pt 6):969-77. PubMed ID: 21378313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Emerging role of Mcl-1 in actively counteracting BH3-only proteins in apoptosis.
    Zhuang J; Brady HJ
    Cell Death Differ; 2006 Aug; 13(8):1263-7. PubMed ID: 16676002
    [No Abstract]   [Full Text] [Related]  

  • 39. Apoptosis by IL-2 deprivation in human CD8+ T cell blasts predominates over death receptor ligation, requires Bim expression and is associated with Mcl-1 loss.
    Bosque A; Marzo I; Naval J; Anel A
    Mol Immunol; 2007 Feb; 44(6):1446-53. PubMed ID: 16806475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation of Mcl-1.
    Mei Y; Du W; Yang Y; Wu M
    Oncogene; 2005 Nov; 24(48):7224-37. PubMed ID: 16007132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.